Bernard, E, Nannya, Y, Yoshizato, T, Hasserjian, RP, Saiki, R, Shiozawa, Y, Devlin, SM, Tuechler, H, Sarian, A, Malcovati, L, Sole, F, Haase, D, Creignou, M, Levine, M, Germing, U, Cargo, C, Zhang, Y, Medina, J, Ossa, JEA, Schanz, J, van de Loosdrecht, A, Jadersten, M, Bennett, JM, Tobiasson, M, Kosmider, O, Follo, MY, Thol, F, Pinheiro, RF, Santini, V, Kotsianidis, I, Boultwood, J, Santos, FPS, Kasahara, S, Ishikawa, T, Tsurumi, H, Akifumi, T-K, Kiguchi, T, Polprasert, C, Klimek, VM, Savona, MR, Belickova, M, Ganster, C, Ades, L, Della Porta, MG, Smith, A, Werner, Y, Patel, MA, Viale, A, Vanness, K, Neuberg, DS, Stevenson, KE, Menghrajani, K, Bolton, K, Fenaux, P, Pellagatti, A, Platzbecker, U, Heuser, M, Valent, P, Chiba, S, Miyazaki, Y, Finelli, C, Voso, MT
, Shih, L-Y, Fontenay, M, Jansen, JH, Cervera, J, Atsuta, Y, Gattermann, N, Ebert, BL, Bejar, R, Greenberg, PL, Cazzola, M, Lindberg, EH, Ogawa, S & Papaemmanuil, E 2019, '
TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes',
Blood, vol. 134.
https://doi.org/10.1182/blood-2019-129392